CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression

Journal of Immunology

Volumn 164, Issue 1, 2000, Pages 144-151

  Appleman, Leonard J ^a   Berezovskaya, Alla ^a   Grass, Isabelle ^a   Boussiotis, Vassiliki A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CYCLIN D2; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; PROTEASOME; PROTEIN P27; UBIQUITIN;

ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; NORMAL HUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 0033976064     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.1.144     Document Type: Article

References (77)

1. Azuma, M., H. Yssel, J. H. Phillips, H. Spits, and L. L. Lanier. 1993. Functional expression of B7/BB1 on activated T lymphocytes. J. Exp. Med. 177:845.
2. Freeman, G. J., A. S. Freedman, J. M. Segil, G. Lee, J. F. Whitman, and L. M. Nadler. 1989. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143:2714.
3. Freeman, G. J., J. G. Gribben, V. A. Boussiotis, J. W. Ng, V. Restivo, L. Lombard, G. S. Gray, and L. M. Nadler. 1993. Cloning of B7-2: a CTLA4 counter-receptor that costimulates human T cell proliferation. Science 262:909.
4. Linsley, P. S., E. A. Clark, and J. A. Ledbetter. 1990. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc. Natl. Acad. Sci. USA 87:5031.
5. Cerdan, C., Y. Martin, M. Courcoul, H. Brailly, C. Mawas, F. Birg, and D. Olive. 1992. Prolonged IL-2 receptor α/CD25 expression after T cell activation via the adhesion molecules CD2 and CD28: demonstration of combined transcriptional and post-transcriptional regulation. J. Immunol. 149:2255.
6. Cerdan, C., Y. Martin, M. Courcoul, C. Mawas, F. Birg, and D. Olive. 1995. CD28 costimulation up-regulates long-term IL-2Rβ expression in human T cells through combined transcriptional and post-transcriptional regulation. J. Immunol 154:1007.
7. Freeman, G. J., V. A. Boussiotis, A. Anumanthan, G. M. Bernstein, X.-Y. Ke, P. D. Rennert, G. S. Gray, J. G. Gribben, and L. M. Nadler. 1995. B7-1 and B7-2 do not deliver identical costimulatory signals since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2:523.
8. June, C. H., J. A. Bluestone, L. M. Nadler, and C. B. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today 15:321.
9. Guerder, S., J. Meyerhoff, and R. Flavell. 1994. The role of the T cell costimulator B7-1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen. Immunity 1:155.
10. Harlan, D. M., H. Hengartner, M. L. Huang, Y. H. Kang, R. Abe, R. W. Moreadith, H. Pircher, G. S. Gray, P. S. Ohashi, G. J. Freeman, L. M. Nadler, C. H. June, and P. Aichele. 1994. Transgenic mice expressing both B7 and viral glycoprotein on pancreatic β cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T lymphocyte unresponsiveness. Proc. Natl. Acad. Sci. USA 91:3137.
11. Verwilghen, J., R. Lovis, M. De Boer, P. Linsley, G. Haines, A. Koch, and R. Pope. 1994. Expression of functional B7 and CTLA4 on rheumatoid synovial T cells. J. Immunol. 153:1378.
12. Chen, L., A. Ashe, W. A. Brady, I. Hellstrom, K. E. Hellstrom, J. A. Ledbetter, P. McGowan, and P. Linsley. 1992. Costimulation of antitumor immunity by the B7 counter receptor for the T lymphocyte molecule CD28 and CTLA-4. Cell 71:1093.
13. + T cells by B7-transfected melanoma cells. Science 259:368.
14. Matulonis, U., C. Dosiou, C. Lamont, G. J. Freeman, P. Mauch, L. M. Nadler, and J. D. Griffin. 1995. Role of B7-1 in mediating an immune response to myeloid leukemia cells. Blood 85:2507.
15. Turka, L. A., P. S. Linsley, H. Lin, W. Brady, J. M. Leiden, R. Q. Wei, M. L. Gibson, X. G. Zheng, S. Myrdal, D. Gordon, T. Bailey, S. F. Bolling, and C. B. Thompson. 1992. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl. Acad. Sci. USA 89:11102.
16. Finck, B., P. Linsley, and D. Wofsy. 1994. Treatment of murine lupus with CTLA4Ig. Science 265:1225.
17. Linsley, P. S., P. M. Wallace, J. Johnson, M. G. Gibson, J. L. Greene, J. A. Ledbetter, C. Singh, and M. A. Tepper. 1992. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257:792.
18. Blazar, B. R., P. A. Taylor, P. S. Linsley, and P. A. Vallera. 1994. In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice. Blood 83:3815.
19. Guinan, E. C., V. A. Boussiotis, D. Neuberg, L. LaVita Brennan, N. Hirano, L. M. Nadler, and J. G. Gribben. 1999. Transplantation of anergic histoincompatible bone marrow allografts. N. Engl. J. Med. 340:1704.
20. Thompson, C. B., T. Lindsten, J. A. Ledbetter, S. L. Kunkel, H. A. Young, S. G. Emerson, J. M. Leiden, and C. H. June. 1989. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc. Natl. Acad. Sci. USA 86:1333.
21. Schorle, H., T. Holtschke, T. Hunig, A. Schimpl, and I. Horak. 1991. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352:621.
22. Shahinian, A., K. Pfeffer, K. P. Lee, T. M. Kundig, K. Kishihara, A. Wakeham, K. Kawai, P. S. Ohashi, C. B. Thompson, and T. W. Mak. 1993. Differential T cell costimulatory requirements in CD28-deficient mice. Science 261:609.
23. Tivol, E. A., F. Borriello, N. A. Schweitzer, W. P. Lynch, J. A. Bluestone, and A. H. Sharpe. 1995. Loss of CTLA4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA4. Immunity 3:541.
24. 1 phase progression: cyclin on cue. Cell 79:551.
25. 1 phase in primary human T lymphocytes. J. Biol. Chem. 268:4113.
26. 1 cyclins in the functional inactivation of the retinoblastoma protein. Genes Dev. 1994:1759.
27. Dynlacht, B. D., O. Flores, J. A. Lees, and E. Harlow. 1994. Differential regulation of E2F transactivation by cyclin/cdk2 complexes. Genes Dev. 8:1772.
28. Chellappan, S. P., S. Hielbert, M. Mudryj, J. M. Horowitz, and J. R. Nevins. 1991. The E2F transcription factor is a cellular target for the Rb protein. Cell 65:1053.
29. Weintraub, S. J., C. A. Prater, and D. C. Dean. 1992. Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358:259.
30. Boussiotis, V. A., G. J. Freeman, G. Gray, J. Gribben, and L. M. Nadler. 1993. B7 but not ICAM-1 costimulation prevents the induction of human alloantigen specific tolerance. J. Exp. Med. 178:1753.
31. Boussiotis, V. A., D. L. Barber, T. Nakarai, G. J. Freeman, J. G. Gribben, G. M. Bernstein, A. L. D'Andrea, J. Ritz, and L. M. Nadler. 1994. Prevention of T cell anergy by signaling through the γc chain of the IL-2 receptor. Science 266:1039.
32. Matsushime, H., D. E. Quekke, S. A. Shurtleff, M. Shibuya, C. J. Sheer, and J. Y. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066.
33. Lee, C. R., S. Yamamoto, H. Wanibuchi, S. Wada, K. Sigamura, T. Kishimoto, and S. Fukushima. 1997. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes and cell proliferation. Cancer Res. 57:4765.
34. waf1/cip1 and p53. Carcinogenesis 20:1697.
35. Boussiotis, V. A., B. J. Lee, G. J. Freeman, J. G. Gribben, and L. M. Nadler. 1997. Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programmed cell death. J. Immunol. 159:3156.
36. 1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14:2077.
37. 0 T cells. J. Immunol. 158:5642.
38. Sherr, C. J. 1996. Cancer cell cycles. Science 274:1672.
39. 1 cyclin-dependent kinases. Genes Dev. 9:1149.
40. Serrano, M., G. J. Hannon, and D. Beach. 1993. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/cdk4. Nature 366:704.
41. Chan, F. K., J. Zhang, L. Cheng, D. N. Shapiro, and A. Winoto. 1995. Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4. Mol. Cell. Biol. 15:2682.
42. Hirai, H., M. F. Roussel, J. Y. Kato, R. A. Ashmun, and C. J. Sherr. 1995. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinase cdk4 and cdk6. Mol. Cell. Biol. 15:2672.
43. Xiong, Y., G. J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366:701.
44. 1 cyclin-dependent kinases. Cell 75:805.
45. kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59.
46. 1 cyclin-cdk protein kinase activity is related to p21. Cell 78:67.
47. kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372: 570.
48. Flores-Rozas, H., Z. Kelman, F. Dean, Z. Pan, J. W. Harper, S. Elledge, M. O'Donnell, and J. Hurwitz. 1994. cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase and holoenzyme. Proc. Natl. Acad. Sci. USA 91:8655.
49. Waga, S., G. J. Hannon, D. Beach, and B. Stillman. 1994. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369:574.
50. Luo, Y., J. Hurwitz, and J. Massague. 1995. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21 Cipl. Nature 375:159.
51. kip1 accumulation during the cell cycle. Science 271:1861.
52. kip1 a cyclin-cdk inhibitor, links transforming factor-b and contact inhibition to cell cycle arrest. Genes Dev. 8:9.
53. kip1) of cyclin-dependent kinase 4 activation. Cell 79:487.
54. Pagano, M., S. W. Tam, A. M. Theodoras, P. Beer-Romero, G. Del Sal, V. Chau, P. R. Yew, G. F. Draetta, and M. Rolfe. 1995. Role of ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682.
55. Kip1 mRNA and protein in murine B cells. J. Immunol. 160:770.
56. Alessandrini, A., D. S. Chiaur, and M. Pagano. 1997. Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation. Leukemia 11:342.
57. Jonston, N. L., and R. E. Cohen. 1991. Uncoupling ubiquitin-protein conjugation from ubiquitin-dependent proteolysis by use of β,γ-nonhydrolyzable ATP analogues. Biochemistry 30:7514.
58. Waterhouse, P., J. M. Penninger, E. Timms, A. Wakenam, A. Shahinian, K. P. Lee, C. B. Thompson, H. Griesser, and T. W. Mak. 1995. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270: 985.
59. Tivol, E. A., S. D. Boyd, S. McKeon, F. Borriello, P. Nickerson, T. B. Strom, and A. H. Sharpe. 1997. CTLA41g prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice. J. Immunol. 158:5091.
60. Mandelbrot, D. A., A. J. McAdam, and A. H. Sharpe. 1999. B7-1 or B7-2 is required to produce the lymphoproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). J. Exp. Med. 189:435.
61. Kip1-deficient mice. Cell 85:733.
62. kip1. Cell 85:721.
63. Bird, J. J., D. R. Brown, A. C. Mullen, N. H. Moskowitz, N. H. Mahowadl, M. A. Sider, T. F. Gajewski, C. R. Wang, and S. L. Reiner. 1998. Helper T cell differentiation is controlled by the cell cycle. Immunity 9:225.
64. kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway. Oncogene 15:629.
65. kip1 down-regulation, passage through the restriction point and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts. Mol. Cell. Biol. 17:5348.
66. Feramisco, J. R., M. Gross, T. Kamata, M. Rosengberg, and R. W. Sweet. 1984. Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells. Cell 38:1009.
67. Peeper, D. S., T. M. Upton, M. H. Ladha, E. Neuman, J. Zalvide, R. Bernards, J. A. DeCaprio, and M. E. Ewen. 1997. Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein. Nature 386:177.
68. Vlach, J., S. Hennecke, and B. Amati. 1997. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J. 16:5334.
69. kip1. Genes Dev. 11:1468.
70. Cenciarelli, C., K. G. Wilhelm, A. Guo, and A. M. Weissman. 1996. T cell antigen receptor ubiquitination is a consequence of receptor-mediated tyrosine kinase activation. J. Biol. Chem. 15:8709.
71. Hou, D., C. Cenciarelli, J. P. Jensen, H. B. Nguyen, and A. M. Weissman. 1994. Activation-dependent ubiquitination of a T cell antigen receptor subunit on multiple intracellular lysines. J. Biol. Chem. 269:14244.
72. August, A., S. Gibson, K. Kawakami, T. Kawakami, G. B. Mills, and B. Dupont. 1994. CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T-cell line. Proc. Natl. Acad. Sci. USA 91:9347.
73. August, A., and B. Dupont. 1994. Activation of src family kinase lck following CD28 crosslinking in the Jurkat leukemic cell line. Biochem. Biophys. Res. 199: 1466.
74. Fyn regulate CD28 binding to phosphatidylinositol 3-kinase, growth factor receptor-bound protein GRB-2, and T cell-specific protein-tyrosine kinase ITK: implications for T-cell costimulation. Proc. Natl. Acad. Sci. USA 92:8891.
75. Boussiotis, V. A., D. L. Barber, B. J. Lee, G. J. Freeman, J. G. Gribben, and L. M. Nadler. 1996. Differential association of protein tyrosine kinases with T cell receptor is linked to the induction of anergy and its prevention by B7 family-mediated costimulation. J. Exp. Med. 184:365.
76. ras. J. Exp. Med. 180:1067.
77. D'Andrea, A., and D. Pellman. 1998. Deubiquitinating enzymes: a new class of biological regulators. Crit. Rev. Biochem. Mol. Biol. 33:337.